These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36156755)

  • 41. Tumor-induced osteomalacia - a mystery illness beyond aches, pains, and depression.
    Ni HJ; Clifton-Bligh R; Brzozowska MM
    Endocr Regul; 2021 Sep; 55(3):163-168. PubMed ID: 34523297
    [No Abstract]   [Full Text] [Related]  

  • 42. Sinonasal hemangiopericytoma caused hypophosphatemic osteomalacia: A case report.
    Li J; Huang Y; Yang F; Zhang Q; Chen D; Wang Q
    Medicine (Baltimore); 2018 Dec; 97(52):e13849. PubMed ID: 30593185
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Tumor localization and treatment of tumor-induced osteomalacia].
    Beil FT; Stürznickel J; Rolvien T; Amling M; Oheim R
    Z Rheumatol; 2022 Apr; 81(3):182-188. PubMed ID: 35103802
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Craniofacial hemangiopericytoma associated with oncogenic osteomalacia: case report.
    Sandhu FA; Martuza RL
    J Neurooncol; 2000; 46(3):241-7. PubMed ID: 10902855
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oncogenic Osteomalacia From a Primary Phosphaturic Mesenchymal Tumor of the Toe: A Case Report.
    Kim I; Rajani R
    J Foot Ankle Surg; 2016; 55(2):294-8. PubMed ID: 25441266
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Tumor-induced rickets/osteomalacia].
    Fukumoto S
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():523-8. PubMed ID: 16279694
    [No Abstract]   [Full Text] [Related]  

  • 47. Hypophosphataemia due to FGF-23 producing B cell non-Hodgkin's lymphoma.
    Elderman JH; Wabbijn M; de Jongh F
    BMJ Case Rep; 2016 Apr; 2016():. PubMed ID: 27118742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor-Induced Osteomalacia.
    Florenzano P; Hartley IR; Jimenez M; Roszko K; Gafni RI; Collins MT
    Calcif Tissue Int; 2021 Jan; 108(1):128-142. PubMed ID: 32504138
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1.
    Hannan FM; Athanasou NA; Teh J; Gibbons CL; Shine B; Thakker RV
    Eur J Endocrinol; 2008 Feb; 158(2):265-71. PubMed ID: 18230836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oncogenic hypophosphataemic osteomalacia mimicking bone metastases on isotope bone scan.
    Dowman JK; Khattak FH
    Ann Rheum Dis; 2006 Dec; 65(12):1664. PubMed ID: 17105854
    [No Abstract]   [Full Text] [Related]  

  • 51. Case records of the Massachusetts General Hospital. Case 33-2011. A 56-year-old man with hypophosphatemia.
    Bergwitz C; Collins MT; Kamath RS; Rosenberg AE
    N Engl J Med; 2011 Oct; 365(17):1625-35. PubMed ID: 22029985
    [No Abstract]   [Full Text] [Related]  

  • 52. Burosumab for the Treatment of Tumor-Induced Osteomalacia.
    Jan de Beur SM; Miller PD; Weber TJ; Peacock M; Insogna K; Kumar R; Rauch F; Luca D; Cimms T; Roberts MS; San Martin J; Carpenter TO
    J Bone Miner Res; 2021 Apr; 36(4):627-635. PubMed ID: 33338281
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.
    Hu FK; Yuan F; Jiang CY; Lv DW; Mao BB; Zhang Q; Yuan ZQ; Wang Y
    Chin J Cancer; 2011 Nov; 30(11):794-804. PubMed ID: 22035861
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Oncogenic osteomalacia: the role of the phosphatonins. Diagnostic usefulness of the Fibroblast Growth Factor 23 measurement in one patient].
    Dupond JL; Magy N; Mahammedi M; Prie D; Gil H; Meaux-Ruault N; Kantelip B
    Rev Med Interne; 2005 Mar; 26(3):238-41. PubMed ID: 15777586
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oncogenic osteomalacia: two case reports with surprisingly different outcomes.
    Seijas R; Ares O; Sierra J; Pérez-Dominguez M
    Arch Orthop Trauma Surg; 2009 Apr; 129(4):533-9. PubMed ID: 19125258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Occult phosphaturic mesenchymal tumour of femur cortex causing oncogenic osteomalacia - diagnostic challenges and clinical outcomes.
    Dutta D; Pandey RK; Gogoi R; Solanki N; Madan R; Mondal A; Dogra S; Thapa P
    Endokrynol Pol; 2018; 69(2):205-210. PubMed ID: 29442350
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Tumor induced osteomalacia].
    Filipová L; Lazúrová I
    Vnitr Lek; 2021; 67(E-8):19-22. PubMed ID: 35459330
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anesthesia for oncogenic osteomalacia--a rare paraneoplastic syndrome.
    Ramachandran R; Rewari V; Trikha A; Singh PM
    Acta Anaesthesiol Taiwan; 2012 Sep; 50(3):134-7. PubMed ID: 23026174
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epidemiology of Tumor-Induced Osteomalacia in Denmark.
    Abrahamsen B; Smith CD; Minisola S
    Calcif Tissue Int; 2021 Aug; 109(2):147-156. PubMed ID: 33818653
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor-induced osteomalacia: experience from a South American academic center.
    González G; Baudrand R; Sepúlveda MF; Vucetich N; Guarda FJ; Villanueva P; Contreras O; Villa A; Salech F; Toro L; Michea L; Florenzano P
    Osteoporos Int; 2017 Jul; 28(7):2187-2193. PubMed ID: 28341900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.